Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis.
Aspeslagh, S., Li, Y., Yu, E.D., Pauwels, N., Trappeniers, M., Girardi, E., Decruy, T., Van Beneden, K., Venken, K., Drennan, M., Leybaert, L., Wang, J., Franck, R.W., Van Calenbergh, S., Zajonc, D.M., Elewaut, D.(2011) EMBO J 30: 2294-2305
- PubMed: 21552205 
- DOI: 10.1038/emboj.2011.145
- Primary Citation of Related Structures:  
3QUX, 3QUY, 3QUZ - PubMed Abstract: 
Invariant natural killer T (iNKT) cells are known to have marked immunomodulatory capacity due to their ability to produce copious amounts of effector cytokines. Here, we report the structure and function of a novel class of aromatic α-galactosylceramide structurally related glycolipids with marked Th1 bias in both mice and men, leading to superior tumour protection in vivo ...